Breaking News Instant updates and real-time market news.

H

Hyatt

$73.44

3.14 (4.47%)

16:24
02/13/19
02/13
16:24
02/13/19
16:24

Hyatt reports Q4 adjusted EPS 62c, consensus 30c

Adjusted EBITDA increased 5.0% to $182M, up 6.8% in constant currency. Comparable system-wide RevPAR increased 1.5%, including an increase of 3.0% at comparable owned and leased hotels. Comparable U.S. hotel RevPAR increased 0.9%; full service and select service hotel RevPAR increased 2.6% and decreased 3.0%, respectively. Comparable owned and leased hotels operating margin increased 240 basis points to 25.1%. The company said, "We had a very strong 2018 driven by another year of double-digit growth in management and franchising fees, nearly offsetting the earnings decline in our owned & leased segment, resulting from over $1.0 billion of asset sales. We successfully closed the acquisition of Two Roads Hospitality LLC, adding five new compelling brands into the Hyatt portfolio and significant future growth opportunities. We believe we are well-positioned to continue to execute our long-term shift to an asset-lighter business model. This is supported by a significant increase in our pipeline, which now stands at approximately 89,000 rooms, equivalent to more than 42% of our system, and our sustained net rooms growth of 7% or better."

  • 14

    Feb

H Hyatt
$73.44

3.14 (4.47%)

01/07/19
BOFA
01/07/19
DOWNGRADE
BOFA
Neutral
Hyatt downgraded to Neutral from Buy at BofA/Merrill
01/07/19
01/07/19
DOWNGRADE
Target $75

Neutral
Hyatt downgraded to Neutral from Buy at BofA/Merrill
As previously reported, BofA/Merrill downgraded Hyatt to Neutral from Buy and cut its price target to $75 from $83. Analyst Shaun Kelley is "lukewarm" on Hyatt's recent Two Roads acquisition saying there could be further contract risk if Hyatt doesn't execute carefully. Further, the departure of CFO Pat Grismer also shuts the door of a strong outsider advocate for the transition to a capital light business, the analyst wrote i a note to investors.
01/08/19
RAJA
01/08/19
DOWNGRADE
RAJA
Market Perform
Hyatt downgraded to Market Perform from Outperform at Raymond James
01/08/19
01/08/19
DOWNGRADE

Market Perform
Hyatt downgraded to Market Perform on more cautious macro view at Raymond James
As previously reported, Raymond James downgraded Hyatt to Market Perform from Outperform. Analyst William Crow said he is taking a more defensive stance towards the broader markets and expectations for a slowing US and global economic backdrop. The analyst said Hyatt's transition has come in "fits and starts," and expects asset sales to slow significantly in 2019.

TODAY'S FREE FLY STORIES

ECIFF

EDF

$0.00

(0.00%)

17:33
02/21/19
02/21
17:33
02/21/19
17:33
Downgrade
EDF rating change  »

EDF downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEE

Lee Enterprises

$2.69

0.075 (2.87%)

17:32
02/21/19
02/21
17:32
02/21/19
17:32
Hot Stocks
Lee Enterprises' TownNews acquires CMS business from GTxcel »

Lee Enterprises announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CENX

Century Aluminum

$9.30

0.12 (1.31%)

17:31
02/21/19
02/21
17:31
02/21/19
17:31
Earnings
Century Aluminum reports Q4 EPS (43c), consensus (53c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EXEL

Exelixis

$21.22

(0.00%)

17:30
02/21/19
02/21
17:30
02/21/19
17:30
Initiation
Exelixis initiated  »

Exelixis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPSN

Epsilon Energy

$0.00

(0.00%)

17:30
02/21/19
02/21
17:30
02/21/19
17:30
Hot Stocks
Epsilon Energy sees 2019 production growth of 27%-33% y/y »

The company anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$14.13

0.245 (1.76%)

17:29
02/21/19
02/21
17:29
02/21/19
17:29
Earnings
SSR Mining sees FY19 gold production 395,000 equivalent ounces »

At the Marigold mine,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ENPH

Enphase Energy

$7.37

0.13 (1.80%)

17:29
02/21/19
02/21
17:29
02/21/19
17:29
Hot Stocks
Park West Asset Management reports 5.4% passive stake in Enphase Energy »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

EPSN

Epsilon Energy

$0.00

(0.00%)

17:29
02/21/19
02/21
17:29
02/21/19
17:29
Hot Stocks
Epsilon Energy board approves $20M-$25M capital budget for 2019 »

Epsilon Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$14.13

0.245 (1.76%)

17:28
02/21/19
02/21
17:28
02/21/19
17:28
Earnings
SSR Mining reports Q4 adjusted EPS 4c, two estimates 0c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BIIB

Biogen

$320.99

-14.02 (-4.18%)

17:28
02/21/19
02/21
17:28
02/21/19
17:28
Initiation
Biogen initiated  »

Biogen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 28

    May

DBX

Dropbox

$25.58

0.1 (0.39%)

17:27
02/21/19
02/21
17:27
02/21/19
17:27
Earnings
Dropbox sees FY19 revenue $1.63B-$1.64B, consensus $1.6B »

Sees FY19 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

QNST

QuinStreet

$13.52

-0.26 (-1.89%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Hot Stocks
Park West Asset Management reports 5.0% passive stake in QuinStreet »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 27

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Earnings
Appian sees FY19 EPS (46c)-(42c), consensus (44c) »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Hot Stocks
S&P announces changes to S&P 400, 500 indices »

Wabtec (WAB) will replace…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

GE

General Electric

$10.03

-0.07 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

DBX

Dropbox

$25.58

0.1 (0.39%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Earnings
Dropbox sees Q1 revenue $379M-$382M, consensus $377.03M »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

EIDX

Eidos Therapeutics

$14.99

-0.64 (-4.09%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Initiation
Eidos Therapeutics initiated  »

Eidos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

NOC

Northrop Grumman

$287.50

-0.73 (-0.25%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Hot Stocks
Northrop Grumman Australia unit to continue work on F-35 program »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

APPN

Appian

$38.73

0.41 (1.07%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Earnings
Appian sees Q1 EPS (17c)-(16c), consensus (12c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

17:22
02/21/19
02/21
17:22
02/21/19
17:22
Earnings
Appian reports Q4 EPS (22c), consensus (16c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

PTGX

Protagonist Therapeutics

$7.32

0.16 (2.23%)

17:20
02/21/19
02/21
17:20
02/21/19
17:20
Initiation
Protagonist Therapeutics initiated  »

Protagonist Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

, WAB

Wabtec

$73.59

-1.425 (-1.90%)

17:20
02/21/19
02/21
17:20
02/21/19
17:20
Hot Stocks
Breaking Hot Stocks news story on Goodyear Tire, Wabtec »

Goodyear Tire to replace…

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

WAB

Wabtec

$73.59

-1.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Hot Stocks
Wabtec to replace Goodyear Tire in S&P 500 at open on 2/27 »

General Electric (GE) is…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BEAT

BioTelemetry

$73.39

-1.98 (-2.63%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Earnings
BioTelemetry reports Q4 EPS 56c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NKTR

Nektar

$40.26

-2.76 (-6.42%)

17:18
02/21/19
02/21
17:18
02/21/19
17:18
Initiation
Nektar initiated  »

Nektar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$52.44

-4.75 (-8.31%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Recommendations
CyrusOne analyst commentary  »

CyrusOne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 11

    Mar

  • 11

    Mar

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.